Rising Asthma Prevalence and the Advent of Covid-19 to Accelerate Demand Growth in the of Respiratory Drug Delivery Formulation Market

Respiratory drugs can be delivered to the body in different ways. The most common form is through inhalation. Oral or intravenous delivery are other common methods. Respiratory drugs are used for the treatment of different respiratory disorders. They include medicines for the treatment of influenza, pneumonia, chronic obstructive pulmonary diseases, and some common forms of allergy such as food allergies and rhinitis.

Market Dynamics

Increasing prevalence of asthma is expected to propel growth of the global respiratory drug delivery formulation market. For instance, According to The Global Asthma Report 2018, around 300 million people have asthma worldwide, and the number is expected to reach 100 million by 2025.
Moreover, initiatives to boost adoption of dry powder inhalers is also expected to aid in growth of the market. For instance, in September 2018, researchers from University of Helsinki, Finland, reported investigation of non-verbal, demonstrational videos as a method of teaching inhaler naïve individuals how to use a dry powder inhaler.
Buy this Report Now @ https://www.coherentmarketinsights.com/insight/buy-now/2649

Emergence of Covid-19 is expected to offer lucrative growth opportunities for players in the global respiratory drug delivery formulation market. For instance, globally, as of 4:32pm CET, 30 December 2020, there have been 80,773,033 confirmed cases of COVID-19, including 1,783,619 deaths, reported to the World Health Organization. Moreover, launch of solutions to track usage pattern of metered-dose inhalers is also expected to aid in growth of the market. For instance, in November 2019, Lupin Ltd. launched a device – Adhero – to track usage pattern of metered-dose inhalers (MDI) by patients suffering from chronic respiratory diseases.
Major players operating in the global respiratory drug delivery formulation market are focused on approval and launch of new products to expand their product portfolio. For instance, in September 2019, Novartis International AG’s Concept1 inhaler received certification under the new EU Medical Devices Regulation (MDR).

Competitive Analysis

Major players operating in the global respiratory drug delivery formulation market include, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline, 3M, AstraZeneca plc, Merck and Co., Inc., Omron Corporation, Novartis AG, Glenmark Pharmaceuticals, Boehringer Ingelheim GmbH, Sunovion Pharmaceuticals Inc., Hovione, Cipla Ltd., Catalent Pharma Solutions, and Aphios Corporation.
Major players operating in the global respiratory drug delivery formulation market are focused on approval and launch of new products to expand their product portfolio. For instance, in April 2019, Glenmark Pharmaceuticals launched two new steroid inhalers that include Soprobec (beclometasone), a metered-dose aerosol inhaler, and Stalpex (salmeterol/fluticasone), a breath-actuated inhaler. Similarly, in April 2019, Cipla Ltd. launched Niveoli, an extra-fine particle beclomethasone-formoterol combination hydrofluoroalkane (HFA) inhaler for adults, which can be used for the treatment of asthma and COPD.
Talk To Analyst @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/2649

Respiratory Drug Delivery Formulation Market- Market Taxonomy
On the basis of formulation type, the global respiratory drug delivery formulation market is segmented into:
• Solution Aerosol
• Suspension Aerosol
• Dry Powder
On the basis of device type, the global respiratory drug delivery formulation market is segmented into:
• Metered Dose Inhaler
• Dry Powder Inhaler
• Nebulizers
On the basis of canister type, the global respiratory drug delivery formulation market is segmented into:
• Plain Canister
• Coated Canister
On the basis of application, the global respiratory drug delivery formulation market is segmented into:
• Chronic Obstructive Pulmonary Disease (COPD)
• Asthma
• Cystic Fibrosis
• Others
On the basis of end user, the global respiratory drug delivery formulation market is segmented into:
• Hospitals and clinics
• Homecare
On the basis of region, the global respiratory drug delivery formulation market is segmented into:
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East
• Africa

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave.
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

For USA (1001 4th Ave, #3200 Seattle, WA 98154, U.S.)
For India (203-204, 2nd Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.)
Website: https://www.coherentmarketinsights.com

CMI has around 150+ analysts working in various sub-verticals, and 50+ functional full-time team members. In addition to this, the company has contract consultants in 24 countries working across the various industry verticals.

This release was published on openPR.